Cargando…
New clinical trial designs in the era of precision medicine
Cancer treatment has made significant strides towards the promise of personalized medicine. Recent scientific advances have shown that there are numerous genetic deregulations that are common in multiple cancer types, raising the possibility of developing drugs targeting those deregulations irrespec...
Autores principales: | Garralda, Elena, Dienstmann, Rodrigo, Piris‐Giménez, Alejandro, Braña, Irene, Rodon, Jordi, Tabernero, Josep |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6396357/ https://www.ncbi.nlm.nih.gov/pubmed/30698321 http://dx.doi.org/10.1002/1878-0261.12465 |
Ejemplares similares
-
Clinical trial design in the era of precision medicine
por: Fountzilas, Elena, et al.
Publicado: (2022) -
The Molecular Tumor Board Portal supports clinical decisions and automated reporting for precision oncology
por: Tamborero, David, et al.
Publicado: (2022) -
Author Correction: The Molecular Tumor Board Portal supports clinical decisions and automated reporting for precision oncology
por: Tamborero, David, et al.
Publicado: (2022) -
Evolving Landscape of Molecular Prescreening Strategies for Oncology Early Clinical Trials
por: Dienstmann, Rodrigo, et al.
Publicado: (2020) -
Precision oncology: separating the wheat from the chaff
por: Remon, Jordi, et al.
Publicado: (2018)